Sapient Contributes to Landmark Study Published in Science Linking Lysosomal Biology and Oxysterol Metabolism to Pulmonary Arterial Hypertension (PAH)
This multi-omics study, led by UPitt researchers, establishes causative linkages between key metabolites & PAH.
Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators
See how the partnership complements Sapient’s mass spectrometry-based proteomics & multi-omics services.
Sapient Announces Leadership Transition to Propel Next Phase of Growth and Innovation
Dr. Jonathan Usuka appointed Chief Executive Officer as Founder Dr. Mohit Jain transitions to Chief Scientific Officer.
Sapient Partners with Rancho BioSciences to Accelerate the Next Generation of its Human Biology Database
See how how the collaboration will enable accelerated delivery of multidimensional insights to inform drug development.
Sapient Contributes to Groundbreaking Study on Human Liver Metabolism Published in Nature Metabolism
The paper details an innovative approach for assaying metabolic activities in intact human liver tissue.
Sapient Announces Expanded, Enhanced Metabolite Identification Capabilities as Significant Advancement in Its Discovery Metabolomics & Lipidomics Services
See how these capabilities enhance the speed, quality & extent of metabolite identification for accelerated insights.
Sapient Appoints Jonathan Usuka as Chief Business Officer
Dr. Usuka will lead global business strategy for commercial collaborations, strategic partnerships & client service innovations.
Sapient Extends Multi-Omics Services with High Throughput Discovery Proteomics
These services enable measure of thousands of proteins in blood and tissue across diverse biological pathways.
Sapient Launches Target Metabolite and Lipid Panels for Focused Biomarker Discovery Analyses with Rapid Time-to-Insight
These ready-to-order panels speed time-to-insight through targeted exploration of known molecules.
Sapient’s High Complexity CLIA Laboratory Receives Accreditation from the College of American Pathologists (CAP)
August 2, 2023—San Diego, CA—Sapient, a biomarker discovery organization providing bespoke services for metabolomics and lipidomics data generation and analysis, announced that its high complexity CLIA laboratory has been awarded accreditation from the College of American Pathologists (CAP). To achieve accreditation, Sapient passed a rigorous evaluation process that involved an in-depth inspection of its clinical… Continue reading Sapient’s High Complexity CLIA Laboratory Receives Accreditation from the College of American Pathologists (CAP)